A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
This clinical drug-drug interaction study is being conducted to evaluate the pharmacokinetics
of dacarbazine(DTIC) when administered in combination with Genasense